Pfizer Inc. (PFE)

Pfizer Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-309	2,119	31,372	21,979	9,159	16,026
Depreciation & Amortization	6,539	6,290	5,064	5,191	4,681	5,755
Share-Based Compensation	640	525	872	1,182	755	687
Other Operating Activities	1,708	-234	-8,041	4,227	-192	-9,881
Operating Cash Flow	8,578	8,700	29,267	32,580	14,403	12,588
Operating Cash Flow Growth	-64.17%	-70.27%	-10.17%	126.20%	14.42%	-20.47%
Capital Expenditures	-3,472	-3,907	-3,236	-2,711	-2,226	-2,046
Acquisitions	-39,939	-43,430	-19,037	0	0	-10,861
Change in Investments	9,710	15,239	6,682	-19,517	-1,672	9,304
Other Investing Activities	-160	-180	-192	-318	-373	-342
Investing Cash Flow	-33,861	-32,278	-15,783	-22,546	-4,271	-3,945
Dividends Paid	-9,316	-9,247	-8,983	-8,729	-8,440	-8,043
Share Issuance / Repurchase	0	0	-2,000	0	0	-8,865
Debt Issued / Paid	33,804	35,945	-3,516	-1,103	-12,755	8,764
Other Financing Activities	-582	-632	-335	16	11,546	-341
Financing Cash Flow	23,906	26,066	-14,834	-9,816	-9,649	-8,485
Exchange Rate Effect	-66	-40	-165	-59	-8	-32
Net Cash Flow	-1,443	2,448	-1,515	159	475	125
Free Cash Flow	5,106	4,793	26,031	29,869	12,177	10,542
Free Cash Flow Growth	-74.73%	-81.59%	-12.85%	145.29%	15.51%	-23.00%
Free Cash Flow Margin	9.27%	8.19%	25.95%	36.74%	29.24%	25.77%
Free Cash Flow Per Share	0.90	0.85	4.64	5.33	2.19	1.89

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).